Minerva Neurosciences | NERV - EPS Earnings Per Share

Stock Price
6.27
Daily Change
-0.04 -0.63%
Monthly
45.14%
Yearly
219.90%
Q1 Forecast
2.46

Minerva Neurosciences reported $-0.56 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
Acadia Pharmaceuticals USD 0.42 0.26 Sep/2025
Adma Biologics USD 0.15 0.01 Sep/2025
ALKERMES USD 0.49 0.03 Sep/2025
Alterity Therapeutics Limited AUD 0 0 Dec/2023
AstraZeneca USD 2.12 0.26 Dec/2025
BioCryst Pharmaceuticals USD -0.13 0.06 Dec/2024
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Cipla INR 15.2 1.52 Dec/2025
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.08 0 Sep/2025
CSL USD 2.06 2.2 Jun/2025
Dynavax Technologies USD 0.21 0.07 Sep/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Grifols EUR 0.26 0.06 Sep/2025
Halozyme Therapeutics USD 1.72 0.18 Sep/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
J&J USD 2.46 0.34 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 2.04 0.38 Sep/2025
Novavax USD -0.76 1.76 Sep/2024
Pfizer USD 0.66 0.21 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
Takeda JPY 65.74 73.57 Dec/2025
Vanda Pharmaceuticals USD -0.09 0 Dec/2024